Pharmacy Times March 23, 2023
Alana Hippensteele, Managing Editor

Research has even shown that cancer diagnosis can be significantly improved using AI, with real-time data updates, personalized attention, and ultimately better results at lower costs.

Over the past decade, there has been a paradigm shift in how we manage different malignancies, including colon cancer, explained Arturo Loaiza-Bonilla, MD, MSEd, FACP, during his keynote presentation at the 2023 NCODA International Spring Forum.

Loaiza-Bonilla, medical director of oncology research at Capital Health, advisory committee member – Government Relations Committee at the American Society of Clinical Oncology (ASCO), co-founder and chief medical officer at Massive Bio, president of the Pennsylvania Society of Oncology and Hematology, and teaching faculty in the Department of Medicine at Drexel University College of Medicine, explained further...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, Provider, Technology, Trends
How healthcare's view of AI has shifted
The Power of Drug Discovery with Philip Tagari
Bite-Sized AI: Why Smaller Models Like Microsoft’s Phi-3 Are Big for Business
Coventry Uni uses AI-generated avatars to train medical students
Lessons on generative AI in medicine from Stanford University

Share This Article